Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer

被引:0
|
作者
Weidong Zhao
Irfan M Hisamuddin
Mandayam O Nandan
Brian A Babbin
Neil E Lamb
Vincent W Yang
机构
[1] Emory University School of Medicine,Department of Medicine, Division of Digestive Diseases
[2] Emory University School of Medicine,Department of Pathology
[3] Emory University School of Medicine,Department of Human Genetics, Division of Digestive Diseases
[4] Winship Cancer Institute,undefined
[5] Emory University School of Medicine,undefined
来源
Oncogene | 2004年 / 23卷
关键词
gut-enriched Krüppel-like factor; GKLF; KLF4; loss of heterozygosity; methylation; point mutation; colon cancer; tumor suppressor;
D O I
暂无
中图分类号
学科分类号
摘要
Krüppel-like factor 4 (KLF4 or GKLF) is an inhibitor of the cell cycle. The gene encoding KLF4 is localized on chromosome 9q, previously shown to exhibit allelic loss in colorectal cancer (CRC). In this study, we show that the mean level of KLF4 mRNA in a panel of 30 CRC was 52% that of paired normal colonic tissues. Similarly, the levels of KLF4 mRNA and protein in a panel of six established CRC cell lines were significantly lower than those of an untransformed colonic epithelial cell line. Using highly polymorphic DNA markers that flank the KLF4 locus, we found evidence for loss of heterozygosity (LOH) in two of eight surgically resected CRC specimens. In addition, LOH was observed in five of six CRC cell lines with one additional cell line exhibiting hemizygous deletion in the KLF4 gene. We also found that the 5′-untranslated region of KLF4 was hypermethylated in a subset of resected CRC specimens and cell lines. Lastly, the open-reading frame of KLF4 in two of three CRC cell lines examined contained several point mutations that resulted in a diminished ability to activate the p21WAF1/Cip1 promoter. These findings indicate that KLF4 is a potential tumor suppressor gene in CRC.
引用
收藏
页码:395 / 402
页数:7
相关论文
共 50 条
  • [21] Expression of Krüppel-like factor 5 in human gastric carcinomas
    Mi Kyung Kwak
    Hyuk-Joon Lee
    Keun Hur
    Do Joong Park
    Hye Seung Lee
    Woo Ho Kim
    Kuhn Uk Lee
    Kuk Jin Choe
    Parry Guilford
    Han-Kwang Yang
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 163 - 167
  • [22] Pleiotropic effects of statins on acute kidney injury: involvement of Krüppel-like factor 4
    Tadashi Yoshida
    Matsuhiko Hayashi
    Clinical and Experimental Nephrology, 2017, 21 : 175 - 181
  • [23] Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation
    Deepak K Kaushik
    Malvika Gupta
    Sulagna Das
    Anirban Basu
    Journal of Neuroinflammation, 7
  • [24] Loss of Krüppel-like factor 9 deregulates both physiological gene expression and development
    Laura Drepanos
    Ian M. Gans
    Janelle Grendler
    Sophia Guitar
    J. Heath Fuqua
    Nathaniel J. Maki
    Andrea R. Tilden
    Joel H. Graber
    James A. Coffman
    Scientific Reports, 13
  • [25] Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
    Pan X.C.
    Chen Z.
    Chen F.
    Chen X.H.
    Jin H.Y.
    Xu X.Y.
    Journal of Zhejiang University SCIENCE B, 2006, 7 (10): : 830 - 836
  • [26] Therapeutic Targeting of Krüppel-Like Factor 4 and Its Pharmacological Potential in Parkinson's Disease: a Comprehensive Review
    Zamanian, Mohammad Yasin
    Golmohammadi, Maryam
    Amin, Rana Sherdil
    Bustani, Ghadeer Sabah
    Romero-Parra, Rosario Mireya
    Zabibah, Rahman S.
    Oz, Tuba
    Jalil, Abduladheem Turki
    Soltani, Afsaneh
    Kujawska, Malgorzata
    MOLECULAR NEUROBIOLOGY, 2024, 61 (06) : 3596 - 3606
  • [27] The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma
    R Piva
    S Deaglio
    R Famà
    R Buonincontri
    I Scarfò
    A Bruscaggin
    E Mereu
    S Serra
    V Spina
    D Brusa
    G Garaffo
    S Monti
    M Dal Bo
    R Marasca
    L Arcaini
    A Neri
    V Gattei
    M Paulli
    E Tiacci
    F Bertoni
    S A Pileri
    R Foà
    G Inghirami
    G Gaidano
    D Rossi
    Leukemia, 2015, 29 : 503 - 507
  • [28] Therapeutic Targeting of Krüppel-Like Factor 4 and Its Pharmacological Potential in Parkinson’s Disease: a Comprehensive Review
    Mohammad Yasin Zamanian
    Maryam Golmohammadi
    Rana Sherdil Amin
    Ghadeer Sabah Bustani
    Rosario Mireya Romero-Parra
    Rahman S. Zabibah
    Tuba Oz
    Abduladheem Turki Jalil
    Afsaneh Soltani
    Małgorzata Kujawska
    Molecular Neurobiology, 2024, 61 : 3596 - 3606
  • [29] Myeloid Krüppel-like factor 2 is a critical regulator of metabolic inflammation
    David R. Sweet
    Neelakantan T. Vasudevan
    Liyan Fan
    Chloe E. Booth
    Komal S. Keerthy
    Xudong Liao
    Vinesh Vinayachandran
    Yoichi Takami
    Derin Tugal
    Nikunj Sharma
    E. Ricky Chan
    Lilei Zhang
    Yulan Qing
    Stanton L. Gerson
    Chen Fu
    Anthony Wynshaw-Boris
    Panjamaporn Sangwung
    Lalitha Nayak
    Paul Holvoet
    Keiichiro Matoba
    Yuan Lu
    Guangjin Zhou
    Mukesh K. Jain
    Nature Communications, 11
  • [30] Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity
    Duyen T Dang
    Xinming Chen
    Jing Feng
    Michael Torbenson
    Long H Dang
    Vincent W Yang
    Oncogene, 2003, 22 : 3424 - 3430